Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant

Bone Marrow Transplantation

Volumn 46, Issue 3, 2011, Pages 368-371

  Smith, A R ^a   Gulbahce, E ^a   Burke, M J ^a   Cao, Q ^a   MacMillan, M L ^a   Tolar, J ^a   Orchard, P J ^a   Blazar, B R ^a   Baker, K S ^b   Wagner, J E ^a   Verneris, M R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

leukemia; pulmonary cytolytic thrombi; relapse; SCT

Indexed keywords

CORTICOSTEROID DERIVATIVE; METHYLPREDNISOLONE; PREDNISONE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA RELAPSE; LUNG DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY CYTOLYTIC THROMBUS; SCHOOL CHILD; UMBILICAL CORD BLOOD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MULTIVARIATE ANALYSIS; PULMONARY EMBOLISM; RECURRENCE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 79952535218     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.119     Document Type: Article

References (16)

1. Gulbahce H, Manivel J, Jessurun J. Pulmonary cytolytic thrombi: a previously unrecognized complication of bone marrow transplantation. Am J Surg Pathol 2000; 24: 1147-1152. (Pubitemid 30612837)
2. Woodard J, Gulbahce E, Shreve M, Steiner M, Peters C, Hite S et al. Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation. Bone Marrow Transplant 2000; 25: 293-300. (Pubitemid 30103019)
3. Peters A, Manivel J, Dolan M, Gulbahce H, Baker K, Verneris M. Pulmonary cytolytic thrombi after allogeneic hematopo-ietic cell transplantation: a further histologic description. Biol Blood Marrow Transplant 2005; 11: 484-485. (Pubitemid 40753801)
4. Morales I, Anderson P, Tazelaar H, Wylam M. Pulmonary cytolytic thrombi: unusual complication of hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2003; 25: 89-92. (Pubitemid 36070973)
5. Smith A, Baker K, Defor T, Verneris M, Wagner J, Macmillan M. Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors. Biol Blood Marrow Transplant 2009; 15: 1086-1093.
6. Verneris M, Brunstein C, Barker J, Macmillan M, Defor T, McKenna D et al. Relapse risk after umbilical cord blood transplantation: enhanced graft versus leukemia effect in recipients of two units. Blood 2009; 114: 4293-4299.
7. Arora M, Nagaraj S, Wagner J, Barker J, Brunstein C, Burns L et al. Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB). Biol Blood Marrow Transplant 2007; 13: 1145-1152. (Pubitemid 47413011)
8. MacMillan ML, Weisdorf DJ, Wagner JE, DeFor TE, Burns LJ, Ramsay NK et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: compar-ison of grading systems. Biol Blood Marrow Transplant 2002; 8: 387-394.
9. Horwitz ME, Sullivan KM. Chronic graft-versus-host disease. Blood Rev 2006; 20: 15-27. (Pubitemid 43106715)
10. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997; 16: 901-910. (Pubitemid 27198953)
11. Kaplan EL, Meier P. Nonparametric estimation from incom-plete observations. JAm Stat Assoc 1958; 53: 457-481.
12. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
13. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
14. Gulbahce H, Pambuccian S, Jessurun J, Woodard P, Steiner M, ManivelJ et al. Pulmonary nodular lesions in bone marrow transplant recipients: impact of histologic diagnosis on patient management and prognosis. Am J Clin Pathol 2004; 121: 205-210. (Pubitemid 38140124)
15. Valcarcel D, Martino R, Pinana J, Sierra J. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease. Curr Opin Oncol 2009; 21 (Suppl 1): S35-S37.
16. Weisdorf D. GVHD the nuts and bolts. Hematology Am Soc Hematol Educ Program 2007, 62-67.